Trademarkia Logo

Australia

AU$
LINSELIR
Cancelled: Cancelled at the request of IB

Last updated on 1 Oct 2015

Owner Info

OSI Pharmaceuticals, LLC

1 Bioscience Park Drive

Farmingdale NY 11735, UNITED STATES OF AMERICA

Serial Number

1449726 filed on 8 Aug 2011

Correspondent

Lawrence E. Abelman, Abelman Frayne & Schwab

666 Third Avenue,,

10th Floor,

UNITED STATES OF AMERICA

LINSELIR

Classification Information


Class [005]
Pharmaceutical preparations for human use for the treatment of cancer

Mark Details


Serial Number

1449726

Registered On

8 Aug 2011

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

17 Feb 2011

Mark Type

US

Legal History


Show more

Status DateAction Taken
1st Oct 2015Cancellation of Entry in Register Published
24th Sept 2015Cancel IP Right
28th May 2015General Correspondence (Application or Registration)
9th Feb 2012IP Right Registration Published
6th Feb 2012Register Trade Mark
6th Feb 2012Application Status
27th Oct 2011IP Right Acceptance Published
23rd Oct 2011Clear Examination report approved
23rd Oct 2011Application Accepted correspondence sent
29th Sept 2011IP Right Filed Published